This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopao [2020/07/09 13:05] – [References] rkoebnik | bacteria:t3e:xopao [2024/12/16 14:45] (current) – [The Type III Effector XopAO from //Xanthomonas//] rkoebnik | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopAO ====== | + | ====== |
- | Author: | + | Author: |
- | Reviewer: Jane Doe | + | |
Class: XopAO\\ | Class: XopAO\\ | ||
Family: XopAO\\ | Family: XopAO\\ | ||
- | Prototype: | + | Prototype: |
- | RefSeq ID:\\ | + | GenBank ID: [[https:// |
+ | RefSeq ID: [[https:// | ||
3D structure: Unknown | 3D structure: Unknown | ||
Line 14: | Line 14: | ||
=== How discovered? === | === How discovered? === | ||
+ | XopAO was predicted to be a type 3 effector based on homology to AvrRpm1, a type 3 effector from // | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
+ | T3SS-mediated translocation of XopAO was assessed by constructing fusion genes with the C-terminal end of AvrBs2 coding sequence (//avrBs2// < | ||
=== Regulation === | === Regulation === | ||